<Record>
<Term>Choline Magnesium Trisalicylate</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Nonsteroidal Antiinflammatory Drug</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Analgesic Agent/Nonnarcotic Analgesic/Analgesic and Antipyretic/Nonsteroidal Antiinflammatory Drug/Choline Magnesium Trisalicylate</ClassificationPath>
<BroaderTerm>Analgesic Agent</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Choline Magnesium Trisalicylate</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Nonsteroidal Antiinflammatory Drug</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Analgesic and Antipyretic</BroaderTerm>
<BroaderTerm>Nonnarcotic Analgesic</BroaderTerm>
<Synonym>Choline Magnesium Trisalicylate</Synonym>
<Synonym>Trilisate</Synonym>
<Synonym>Trisalicylate</Synonym>
<Description>A nonsteroidal anti-inflammatory drug (NSAID) belonging to the salicylate family.  Choline magnesium trisalicylate inhibits inflammation-related prostaglandin synthesis. This agent's analgesic effect is mediated through peripheral and central pathways, resulting in a decrease in pain perception; its antipyretic effect is mediated via the hypothalamic heat regulation center. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
